Balyasny Asset Management’s Apogee Therapeutics APGE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$6.89M	Buy	158,635 +45,905	+41%	+$1.99M	0.01%	789
2025 Q1	$4.21M	Buy	+112,730	New	+$4.21M	0.01%	911
2024 Q2	–	Sell	-3,561	Closed	-$237K	–	1906
2024 Q1	$237K	Buy	+3,561	New	+$237K	﹤0.01%	1734